Therapeutic deep eutectic solvents: A comprehensive review of their thermodynamics, microstructure and drug delivery applications MM Abdelquader, S Li, GP Andrews, DS Jones European Journal of Pharmaceutics and Biopharmaceutics, 2023 | 26 | 2023 |
Inhibition of co-crystallization of olmesartan medoxomil and hydrochlorothiazide for enhanced dissolution rate in their fixed dose combination MM Abdelquader, EA Essa, GM El Maghraby AAPS PharmSciTech 20, 1-12, 2019 | 22 | 2019 |
Smart liquids for oral controlled drug release: An overview of alginate and non-alginate based systems EA Essa, TT Elebyary, MM Abdelquader, GM El Maghraby, AA Elkordy Journal of Drug Delivery Science and Technology 61, 102211, 2021 | 10 | 2021 |
Co-processing of Atorvastatin and Ezetimibe for Enhanced Dissolution Rate: In Vitro and In Vivo Correlation MF Arafa, RA Alshaikh, MM Abdelquader, GM El Maghraby AAPS PharmSciTech 22, 1-11, 2021 | 5 | 2021 |
Factors governing the formation of THEDESs: A case study with propionic acid NSAIDs and lidocaine MM Abdelquader, S Li, GP Andrews, DS Jones British Journal of Pharmacy 7 (2), S1-S2, 2022 | 3 | 2022 |
Towards a greater understanding of the deep eutectic phenomenon through examination of the lidocaine-NSAID therapeutic deep eutectic systems S Li, MM Abdelquader, GP Andrews, DS Jones European Journal of Pharmaceutics and Biopharmaceutics, 114329, 2024 | | 2024 |
THEDES as a drug product intermediate for improved melt-extrusion processibility of thermally labile active ingredients MM Abdelquader, S Li, GP Andrews, DS Jones British Journal of Pharmacy 8 (2), S1-S2, 2023 | | 2023 |
Towards a Greater Understanding of the Deep Eutectic Phenomenon Through Examination of the Lidocaine-NSAID Therapeutic Deep Eutectic Systems D Jones, S Li, MM Abdelquader, GP Andrews Available at SSRN 4732149, 0 | | |